Skip to content
value.today

Elektrofi, Inc.

Total raised
$155 M
2 rounds on record
Latest round
$112 M
Aug 2024
First round on record
May 2022
Today
Acquired
Acquired by Halozyme Therapeutics, Inc.

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of Elektrofi, Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Elektrofi, IncHalozyme Therapeutics, Inc.2025—$810 M—Annual report

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Elektrofi, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2024$112 MNo. 2$50 to $250 million

Elektrofi, Inc.: Raise no. 2, Aug 2024

Investors in this round

21 investors had bought by the notice of Oct 15, 2024: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$112 M of $112 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series C Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Coffman · Director, Executive Officer · Mr. Coffman is the President and Secretary of the Issuer.
  • Jason Norris · Director, Executive Officer · Mr. Norris is the Vice President and Treasurer of the Issuer.
  • Andrew L. Goldberg · Director
  • Arman L. Gupta · Director
  • Charles L. Cooney · Director
  • Constantine L. Chinoporos · Director
  • Noel L. Jee · Director
  • Peter L. Bojo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chase Coffman, Chief Executive Officer and President of the Issuer. Source: SEC Form D and 1 amendment, newest notice filed Oct 15, 2024. Read the notice at the SEC.

equitySEC
May 2022$43 MNo. 1$10 to $50 million

Elektrofi, Inc.: Raise no. 1, May 2022

Investors in this round

23 investors had bought by the notice of Jun 22, 2022: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$43 M of $43 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock and Class A Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chase Coffman · Executive Officer, Director · Mr. Coffman is the President and Secretary of the Issuer.
  • Jason Norris · Executive Officer, Director · Mr. Norris is the Vice President and Treasurer of the Issuer.
  • Andrew L. Goldberg · Director
  • Charles L. Cooney · Director
  • Constatine L. Chinoporos · Director
  • Sam L. Huang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jason Norris, Vice President of the Issuer. Source: SEC Form D, newest notice filed Jun 22, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Elektrofi, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2024).

    SEC Form D · Oct 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2024

That is all the official record says: Elektrofi, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Elektrofi, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Elektrofi, Inc.
NameRoleNamed in
Chase CoffmanMr. Coffman is the President and Secretary of the Issuer.Oct 2024
Jason NorrisMr. Norris is the Vice President and Treasurer of the Issuer.Oct 2024
Andrew L. GoldbergDirectorOct 2024
Arman L. GuptaDirectorOct 2024
Charles L. CooneyDirectorOct 2024
Chase CoffmanMr. Coffman is the President and Secretary of the Issuer.Oct 2024
Constantine L. ChinoporosDirectorOct 2024
Jason NorrisMr. Norris is the Vice President and Treasurer of the Issuer.Oct 2024
Noel L. JeeDirectorOct 2024
Peter L. BojoDirectorOct 2024
Constatine L. ChinoporosDirectorJun 2022
Sam L. HuangDirectorJun 2022

Acquired (Jan 1, 2025). Acquired by Halozyme Therapeutics, Inc..